DISCLOSURE OF INSIDE INFORMATION BY EMERALD HORIZON AG PURSUANT TO ARTICLE 17 PARA 1 OF THE MARKET ABUSE REGULATION

Management Board member and majority shareholder Florian Wagner commits to provide additional equity financing in the amount of EUR 20 million.

Vienna, 30 June 2026.

At today’s meeting of the Supervisory Board of Emerald Horizon AG (the “Company”), the Supervisory Board agreed with Management Board member and majority shareholder Florian Wagner on the key terms of a future equity financing by, or with the participation of, Mr Wagner as lead investor. Mr Wagner commits to provide the Company with further equity capital in the amount of EUR 20 million in four tranches over a two-year period, in addition to the equity financing already carried out in June 2026 in the amount of EUR 5,021,815.14 (of which Florian Wagner’s share amounted to EUR 3,000,469.93).

The following terms are to be agreed in an investment agreement between the Company and Mr Wagner, which remains to be finally negotiated and entered into:

• Florian Wagner will provide the Company with equity capital in a total amount of EUR 20 million against the issue of new shares by way of a capital increase from authorized capital, excluding the subscription rights of the Company’s existing shareholders, in four equal tranches of EUR 5 million each.
• The tranches are to be provided at semi-annual intervals, with the Company being entitled to call them as follows: the first tranche during the period from October 2026 until no later than the end of March 2027 (Q4 2026/Q1 2027), the second tranche during Q2/Q3 2027, the third tranche during Q4 2027/Q1 2028 and the fourth tranche during Q2 2028/Q3 2028.
• Florian Wagner will be granted the right to nominate one or more persons to take up the respective tranche, in whole or in part, in his place. In this context, a small portion of co-investment by the second-largest shareholder Philipp Pölzl and Carl Page as a new investor will be confirmed, among others.
• The subscription price per new share is to be determined on the basis of the volume-weighted average price of the Company’s shares during the last 30 trading days prior to the date of the respective framework resolution on the call-off of one of the tranches.

The committed equity funds are intended to be used in particular to finance the continued cooperation with partner VDL Groep in connection with the co-development of the prototype of the core technology ADES and to strengthen our collaboration with Royal HaskoningDHV in the area of regulatory affairs. In addition, the financing is intended to strengthen the Company’s liquidity base. Finally, it is intended to enable the Company to make use of available funding programmes, thereby further enhancing the positive effects of the equity contribution.

Legal Notice / Disclaimer:

This announcement constitutes a mandatory disclosure pursuant to Article 17 of the Market Abuse Regulation. The information contained in this announcement does not constitute an offer to sell or a solicitation of an offer to purchase or subscribe for securities and does not constitute a recommendation to purchase or sell securities of the Company.

The information contained in this announcement and on the websites referred to herein is not intended, under any circumstances, for publication, distribution or transmission, directly or indirectly, in whole or in part, in or into the United States of America (USA), Australia, Canada, Japan or South Africa or any other jurisdiction where such publication or transmission would be unlawful. Accordingly, the information is not directed, in particular, at “U.S. persons” within the meaning of Regulation S under the U.S. Securities Act of 1933 or at persons who are resident or located in the aforementioned jurisdictions.

2356964  30-Jun-2026 CET/CEST